EPO and hydrops fetalis: However, in the RED-HF trial, an increase in the hematocrit by erythropoietin injection showed no association with prognostic improvement, indicating that this effect could be attributed to reduction in plasma volume rather than increasing the circulating concentration of erythropoietin (53).